HIV - Antiretrovirals (ARVs) Reports Tuberculosis (TB)

Report: Stock outs in South Africa – a national crisis

Written by Health-e News

Released by a civil society consortium, this report shows that one-in-five health centers surveyed had experienced drug shortages or stock outs recently.

With about 2.4 million people on antiretroviral therapy (ART) and more than 300,000 people treated for tuberculosis (TB) every year, South Africa has the largest HIV treatment programme in the world and an enormous associated TB treatment programme.

Ensuring regular and uninterrupted supply of antiretroviral (ARVs) and TB medicines is critical for its success.

To quantify the extent of ARV, TB and vaccine stock outs at the provincial and national level, the Stop Stock Outs Project undertook a national telephonic survey between September and October 2013.

The project is a joint effort by organizations including Medicines Sans Frontieres, the Treatment Action Campaign and the Southern African HIV Clinicians’ Society.

Stock outs in South Africa – a national crisis

 

About the author

Health-e News

Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews